ENOS anticorps (Ser1179)

N° du produit ABIN5961401

Détail du produit anti-ENOS anticorps

Antigène: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Épitope: Ser1179

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ENOS est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificité: CNOS,Constitutive NOS,EC NOS,EC-NOS,ecNOS,Endothelial nitric oxidase synthase,Endothelial nitric oxide synthase,Endothelial nitric oxide synthase 3,Endothelial NOS,eNOS,Nitric oxide synthase 3 (endothelial cell),Nitric oxide synthase 3,Nitric oxide synthase 3 endothelial cell,Nitric oxide synthase endothelial,Nitric oxide synthase,endothelial,NOS 3,NOS III,NOS type III,NOS3,NOS3,NOSIII

Purification: Affinity purification

Immunogène: Synthesized peptide derived from human NOS3 around the non-phosphorylation site of Ser1179.

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-2000, IHC 1:50-300, IF 1:50-300

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % sodium azide, 0.5 % BSA and 50 % glycerol, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur ENOS

Antigène: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Autre désignation: NOS3 (NOS3 Produits)

Synonymes: anticorps ECNOS, anticorps eNOS, anticorps 2310065A03Rik, anticorps Nos-3, anticorps ecNOS, anticorps EC-NOS, anticorps NOSIII, anticorps cNOS, anticorps NOS, anticorps NOS3, anticorps eNos, anticorps ENOS, anticorps nitric oxide synthase 3, anticorps nitric oxide synthase 3, endothelial cell, anticorps NOS3, anticorps Nos3, anticorps nos3

Sujet: Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.

Poids moléculaire: 133kDa

ID gène: 4846

UniProt: P29474

Pathways: ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling